IRIS
GALEAZZI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 38.880
EU - Europa 30.261
AS - Asia 15.169
SA - Sud America 2.727
AF - Africa 704
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 30
AN - Antartide 1
Totale 87.818
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 38.484
GB - Regno Unito 9.289
CN - Cina 5.750
RU - Federazione Russa 4.975
SG - Singapore 4.714
IE - Irlanda 3.629
UA - Ucraina 2.762
BR - Brasile 2.296
IT - Italia 2.146
SE - Svezia 2.068
FR - Francia 1.853
DE - Germania 1.823
VN - Vietnam 1.329
HK - Hong Kong 1.152
FI - Finlandia 896
KR - Corea 703
IN - India 347
ZA - Sudafrica 322
CA - Canada 200
BD - Bangladesh 173
TR - Turchia 173
AR - Argentina 156
ES - Italia 152
IQ - Iraq 151
NL - Olanda 141
MX - Messico 116
PL - Polonia 108
NG - Nigeria 106
JP - Giappone 99
BE - Belgio 94
ID - Indonesia 74
CI - Costa d'Avorio 68
PK - Pakistan 65
EC - Ecuador 63
CZ - Repubblica Ceca 56
VE - Venezuela 51
MA - Marocco 50
SA - Arabia Saudita 48
UZ - Uzbekistan 43
AT - Austria 42
CO - Colombia 41
AU - Australia 36
TN - Tunisia 36
CL - Cile 32
LT - Lituania 32
KE - Kenya 30
JO - Giordania 29
PH - Filippine 29
AE - Emirati Arabi Uniti 28
NP - Nepal 28
EG - Egitto 27
KZ - Kazakistan 26
PY - Paraguay 26
EU - Europa 25
IR - Iran 25
PE - Perù 25
MY - Malesia 24
GR - Grecia 23
CH - Svizzera 22
IL - Israele 21
DZ - Algeria 20
UY - Uruguay 20
BG - Bulgaria 19
AZ - Azerbaigian 16
DO - Repubblica Dominicana 16
RO - Romania 16
DK - Danimarca 15
BO - Bolivia 14
AL - Albania 13
PT - Portogallo 13
KG - Kirghizistan 12
LB - Libano 12
JM - Giamaica 11
KW - Kuwait 11
CR - Costa Rica 10
ET - Etiopia 10
HU - Ungheria 10
OM - Oman 10
RS - Serbia 9
SK - Slovacchia (Repubblica Slovacca) 9
TH - Thailandia 9
BH - Bahrain 8
SY - Repubblica araba siriana 8
TT - Trinidad e Tobago 8
PA - Panama 7
AM - Armenia 6
HN - Honduras 6
HR - Croazia 6
LU - Lussemburgo 6
LV - Lettonia 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
TW - Taiwan 6
AO - Angola 5
CY - Cipro 5
EE - Estonia 5
KH - Cambogia 5
SN - Senegal 5
BN - Brunei Darussalam 4
BY - Bielorussia 4
Totale 87.719
Salva come PNG Salva come JPEG
Città #
Southend 8.573
Dallas 4.320
Fairfield 3.987
Dublin 3.590
Ashburn 2.775
Singapore 2.704
Menlo Park 2.345
Chandler 2.254
Jacksonville 2.231
Woodbridge 1.895
Houston 1.876
Wilmington 1.546
Seattle 1.490
Beijing 1.342
Cambridge 1.336
Santa Clara 1.326
Moscow 1.300
Ann Arbor 1.161
Hong Kong 1.101
San Jose 843
Nanjing 761
Princeton 733
Hefei 723
The Dalles 680
Seoul 678
Siena 529
New York 452
Los Angeles 442
Ho Chi Minh City 417
Lauterbourg 387
Helsinki 380
Boardman 335
Hanoi 324
San Mateo 316
Johannesburg 290
Munich 281
Nanchang 251
San Diego 251
Buffalo 234
São Paulo 213
Council Bluffs 196
Dearborn 178
Shenyang 178
Columbus 172
Düsseldorf 160
Shanghai 142
Tianjin 133
Changsha 130
Hebei 126
Milan 110
Orem 109
Jiaxing 106
Venezia 104
Abuja 102
Rome 100
London 95
Málaga 95
Dong Ket 90
Kunming 89
Turku 89
Brussels 88
Lancaster 86
Toronto 84
Jinan 83
Tokyo 83
Frankfurt am Main 81
Guangzhou 79
Rio de Janeiro 77
San Francisco 77
Warsaw 75
Chennai 71
Bengaluru 70
Abidjan 68
Redondo Beach 67
Belo Horizonte 66
Brooklyn 66
Norwalk 66
Zhengzhou 65
Da Nang 63
Izmir 60
Washington 59
Montreal 56
Chicago 54
Saint Petersburg 53
Baghdad 52
Denver 51
Haiphong 50
Hangzhou 50
Mestre 50
Ningbo 50
Stockholm 47
Boston 44
Changchun 44
Falls Church 44
Brasília 43
Florence 43
Amsterdam 42
Redwood City 42
Dhaka 41
Tashkent 39
Totale 61.605
Salva come PNG Salva come JPEG
Nome #
UNIREUMA -REUMATOLOGIA PER STUDENTI E MEDICI DI MEDICINA GENERALE I EDIZIONE 629
Comparison of combination therapies in the treatment of rheumatoid arthritis :leflunomide-anti-TNF-alfa versus methotrexate-anti-TNF-alfa 462
Livello sierico della COMP (Cartilage Oligomeric Matrix Protein): Uso potenziale come marker di progressione del danno articolare nei pazienti con "Early Rheumatoid Arthritis" 461
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 415
null 412
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 400
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 394
Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung 375
Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation 358
Expression of RXFP1 in skin of scleroderma patients and control subjects 353
A "new" technique for the diagnosis of chondrocalcinosis of the knee: sensitivity and specificity of high-frequency ultrasonography 353
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms 350
Alkaptonuria is a novel human secondary amyloidogenic disease 348
AB0969 Accuracy of blind intra-articular injections in patients with osteoarthritis of the knee. An ultrasonography controlled study 347
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 344
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 342
AB0535 Effects of tocilizumab on bone density and metabolism in patients with active rheumatoid arthritis 333
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 326
A novel ex vivo organotypic culture model of alkaptonuria-ochronosis 313
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 313
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 312
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 311
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry 311
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 310
A case of amyloid myopathy in a patient with familial Mediterranean fever 310
Bone mineral density in patients with systemic sclerosis. 309
Deltoideal acromial enthesopathy in ankylosing spondylitis and in spondylarthropathies: comment on the article by Lambert et al. 308
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 308
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 308
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 308
Change perspective to increase diagnostic accuracy of ultrasonography in calcium pyrophosphate dehydrate deposition disease! A new approach: The axial scan of the meniscus 305
Circulating levels of adiponectin, resistin, and visfatin after mud-bath therapy in patients with bilateral knee osteoarthritis 302
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes 299
AB1308 Prevalence of baker’s CYST in patients with chronic gonalgia and relationship with major non inflammatory diseases 296
Colchicine myopathy and neuromyopathy: two cases with different characteristics 295
Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature 295
Absence of anti-cyclic citrullinated peptide antibodies in erosive osteoarthritis: further serological evidence of the disease as a subset of osteoarthritis 294
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 291
High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus 291
Obesity reduces the response rate to anti TNFα in rheumatoidarthritis. an approach to a personalized medicine 290
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis 289
A whitish-creamysynovial fluid. 289
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 289
Could oxidative stress regulate the expression of microRNA-146a and microRNA-34a in human osteoarthritic chondrocyte cultures? 289
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. 288
Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations 285
Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis 284
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection 284
Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed. 283
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 283
Validation of an Italian version of the functional index for hand osteoarthritis (FIHOA) 281
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 280
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 280
FRI0501 Ultrasound versus synovial fluid analysis for the diagnosis of calcium pyrophosphate dihydrate deposition disease: preliminary results 280
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 278
Ultrasonography and magnetic resonance imaging of heel fat pad inflammatory-oedematous lesions in rheumatoid arthritis 277
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 270
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 269
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 266
One-year follow-up of mud-bath therapy in patients with bilateral knee osteoarthritis: a randomized, single-blind controlled trial 262
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 262
Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients 259
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus 258
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 256
Granulomatosis with polyangiitis and intravenous immunoglobulins: A case series and review of the literature 256
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 256
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 256
Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk 256
Hydrostatic pressure regulates MicroRNA expression levels in osteoarthritic chondrocyte cultures via the Wnt/β-catenin pathway 254
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 252
SAT0312 Ultrasound Reliability in the Diagnosis of Calcium Pyrophosphate Deposition Disease: Agreement Between Observers and Main Causes of Discordance 252
The Immunogenetics of the Antiphospholipid Syndrome, Anticardiolipin Antibodies, and Lupus Anticoagulant 251
Anticardiolipin and antibeta2GPI antibodies In a large series of european patients with systemic lupus erythematosus: prevalence and clinical association 250
A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus 249
SAT0564 Articular Involvement in Behçet Disease: An Ultrasonographic Study 248
Can hybrid hyaluronic acid represent a valid approach to treat rizoarthrosis? A retrospective comparative study 247
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 246
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease 245
Chromosomal abnormalities in peripheral lymphocytes from idiopathic Raynaud's phenomenon patients 245
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 244
Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients 243
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 242
FRI0533 Ultrasonographic Features of Joints and Entheses in Healty Children 242
Autoinflammatory disorders and patients with isolated serosal involvement. 241
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 241
Weekly oral alendronate in mevalonate kinase deficiency 239
Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments 239
SAT0542 The Prevalence of Calcium Pyrophosphate Deposits at Ultrasound Examination: Retrospective Analysis in A Cohort of Patients 238
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 238
Anomalie cromosomiche, valutate come frequenza di micronuclei spontanei, in soggetti con fenomeno di Raynaud sospetto presclerodermico [Chromosome aberrations, valued as frequency of spontaneous micronuclei, in subjects with suspected presclerodermic Raynaud's phenomenon] 238
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 237
Chromosome aberrations in Raynaud's phenomenon 237
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 236
Fasitibant prevents the bradykinin andinterleukin 1β synergism on prostaglandin E(2) release and cyclooxygenase 2expression in human fibroblast-like synoviocytes 235
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 235
Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection 234
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 233
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 233
Treatment of rheumatic diseases in patients with HCV and HIV infection 233
Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies 232
Totale 29.075
Salva come PNG Salva come JPEG
Categoria #
all - tutte 251.055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 251.055
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.818 0 0 0 0 0 0 0 0 0 587 633 598
2021/20226.291 532 765 428 492 430 157 257 243 441 736 588 1.222
2022/20238.003 532 576 1.072 1.182 870 1.648 107 628 831 163 255 139
2023/20245.257 231 130 437 298 187 1.545 1.745 142 24 61 71 386
2024/202510.463 229 606 855 614 1.278 528 250 615 843 403 1.251 2.991
2025/202622.965 1.941 3.979 3.078 2.858 4.771 1.122 2.612 749 747 1.108 0 0
Totale 88.381